Medtronic plc.

Open: 81.81 Close: 81.11 Change: -0.7

The top 13 things about Medtronic plc. found by an AI.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, stock, FDA, plc, approve, PulseSelect, PFA, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

S&P 500 Index SPX, -0.95% rising 0.45% to 4,740.56 and the Dow Jones Industrial Average DJIA remained mostly unchanged at 37,306. Medtronic announces cash dividend for third quarter of fiscal year 2024.

Today's News

Medtronic plc stock outperforms competitors on strong trading day - marketwatch.com. The S&P 500 Index SPX, -0.95% rising 0.45% to 4,740.56 and the Dow Jones Industrial Average DJIA remained mostly unchanged at 37,306. Medtronic announces cash dividend for third quarter of fiscal year 2024. Board of directors approved the companys cash dividend on December 7, 2023. FDA approves Medtronics blood pressure treatment device for use. Medtronic has received approval from the US Food and Drug Administration (FDA) for its PulseSelect pulsed field ablation (PFA) system to treat both paroxysmal and persistent atrial fibrillation. Markets close in 58 minutes S&P 500 4,722.93 -45.44 (-0.44%) Dow 30 37,299.01 -258.91 (-069%) Nasdaq 14,860.63 -142.60 (-00.60%) Russell 2000 2,022.90 +1.95 (+0.10%) Crude Oil 74.11 -39:7629 Zystyleotive stripes Details 1888 8000Socket 1895 recre Panama= 360 AW Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation. The PulseSelect PFA system is also the first FDA Breakthrough-designated PFA technology to be approved. Vestor Capital LLCs holdings in Medtronic were worth $59,000 at the end of the most recent quarter. Medtronic plc (mdt) news, articles, events & latest updates. Shares crossed below their 200 day moving average. Medtronic plc (NYSE: MDT) PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF) The FDA approved 2 renal denervation devices. Medtronic stock price per share is $82.07 today (as of Dec 19, 2023) Medtronics stock was originally listed at a price of $26.25 in Dec 31, 1997. If you had invested in Medtronade stock at $26., your return over the last 25 years would have been 212.65%. Medtronic plc (NYSE:MDT) is about to go ex-dividend in the next four days. The medical device maker recently announced a dividend of $0.69 per share, payable on 2024-01-2020. The company has made 116 investments. Medtronic recently partnered with NUI Galway on October 10, 2023. Piper Sandler maintains a Hold rating on Medtronics with a price target of $87.00. The analyst consensus on the stock is a Moderate Buy with an average price target.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, stock, FDA, plc, approve, PulseSelect, PFA, and the most common words in the summary are: medtronic, stock, mdt, job, plc, market, medical, . One of the sentences in the summary was: S&P 500 Index SPX, -0.95% rising 0.45% to 4,740.56 and the Dow Jones Industrial Average DJIA remained mostly unchanged at 37,306. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #mdt #job #plc #market #medical.